Search results
Results From The WOW.Com Content Network
Future Oncology is a peer-reviewed medical journal established in ... the journal has a 2022 impact factor of 3. ... This page was last edited on 15 November 2023, ...
Radiotherapy & Oncology is a peer-reviewed medical journal in the field of radiation oncology. Commonly referred to as "The Green Journal", it is published by Elsevier on behalf of the European Society for Radiotherapy and Oncology. [1] According to the Journal Citation Reports, the journal has a 2023 impact factor of 4.9. [2]
Cellular Oncology is a bimonthly peer-reviewed medical journal published by Springer Science+Business Media. [1] The journal was established in 1989 as Analytical Cellular Pathology, obtaining its current name in 2003. [2] [3] It is an official publication of the International Society for Cellular Oncology and is published
JCO Global Oncology is a peer-reviewed open-access medical journal covering cancer care, research, and care delivery issues unique to countries and settings with limited healthcare resources. It was established in 2015 as the Journal of Global Oncology , obtaining its current name in 2020.
The Journal of Clinical Oncology is a peer-reviewed medical journal published 3 times a month by the Lippincott Williams & Wilkins. It covers research on all aspects of clinical oncology. The journal was established in 1983 and the editor-in-chief is Jonathan W. Friedberg (University of Rochester). JCO's Impact Factor is 45.3 as reported by ...
It publishes the NCCN Clinical Practice Guidelines in Oncology, updates and review articles elaborating on guideline recommendations, and health services and clinical research papers, as well as correspondence and commentaries.
Molecular Oncology is a monthly peer-reviewed open-access medical journal covering research in molecular oncology. It is published by Wiley on behalf of the Federation of European Biochemical Societies. The journal regularly publishes thematic issues with review articles focusing on specific topics of basic, translational, or clinical cancer ...
Oncogene received a 2023 impact factor of 6.9 and received Journal Citation Reports rankings of 18th out of 191 in the category Genetics & Heredity, 29th out of 205 in the category Cell Biology, 32nd out of 313 in the category Biochemistry & Molecular Biology, and 43rd out of 322 journals in the category Oncology. [3]